Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Campbell McInnes

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Drug Discovery Today|July 22, 2008
Progress in the evaluation of CDK inhibitors as anti-tumor agentsCampbell McInnes
Idrugs : the Investigational Drugs Journal|June 24, 2005
PharmaDiscovery 2005. Kinases in drug discoveryCampbell McInnes
Current Opinion in Drug Discovery & Development|May 30, 2006
Improved lead-finding for kinase targets using high-throughput dockingCampbell McInnes
Journal of Medicinal Chemistry|December 12, 2024
Overcoming Resistance to FLT3-ITD TherapeuticsCampbell McInnes
Current Opinion in Chemical Biology|October 16, 2007
Virtual screening strategies in drug discoveryCampbell McInnes
Idrugs : the Investigational Drugs Journal|June 16, 2004
Cambridge Healthtech Institute fourth annual conference in structure-based drug designCampbell McInnes
Oncogene|April 10, 2020
RAF kinase dimerization: implications for drug discovery and clinical outcomesTilman Brummer, Campbell McInnes
Idrugs : the Investigational Drugs Journal|April 6, 2006
Structure-based discovery and optimization of potential cancer therapeutics targeting the cell cycleMark P Thomas, Campbell McInnes
Drug Discovery Today|May 24, 2011
PLK1 as an oncology target: current status and future potentialCampbell McInnes, Michael D Wyatt
Current Pharmaceutical Design|May 17, 2005
Strategies for the design of potent and selective kinase inhibitorsCampbell McInnes, Peter M Fischer
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Drug Discovery Today|July 22, 2008
Progress in the evaluation of CDK inhibitors as anti-tumor agentsCampbell McInnes
Idrugs : the Investigational Drugs Journal|June 24, 2005
PharmaDiscovery 2005. Kinases in drug discoveryCampbell McInnes
Current Opinion in Drug Discovery & Development|May 30, 2006
Improved lead-finding for kinase targets using high-throughput dockingCampbell McInnes
Journal of Medicinal Chemistry|December 12, 2024
Overcoming Resistance to FLT3-ITD TherapeuticsCampbell McInnes
Current Opinion in Chemical Biology|October 16, 2007
Virtual screening strategies in drug discoveryCampbell McInnes
Idrugs : the Investigational Drugs Journal|June 16, 2004
Cambridge Healthtech Institute fourth annual conference in structure-based drug designCampbell McInnes
Oncogene|April 10, 2020
RAF kinase dimerization: implications for drug discovery and clinical outcomesTilman Brummer, Campbell McInnes
Idrugs : the Investigational Drugs Journal|April 6, 2006
Structure-based discovery and optimization of potential cancer therapeutics targeting the cell cycleMark P Thomas, Campbell McInnes
Drug Discovery Today|May 24, 2011
PLK1 as an oncology target: current status and future potentialCampbell McInnes, Michael D Wyatt
Current Pharmaceutical Design|May 17, 2005
Strategies for the design of potent and selective kinase inhibitorsCampbell McInnes, Peter M Fischer
Pageof 7